Call Us
Overview of Surgery for Ovarian Cancer

Overview of Surgery for Ovarian Cancer

What is ^Surgery for Ovarian Cancer?

Surgery is a fundamental component of ovarian cancer treatment, aimed at removing all visible tumors through cytoreductive procedures tailored to the extent of the disease. In contrast to a breast cancer lumpectomy, ovarian surgery involves comprehensive staging and the removal of peritoneal metastases, which helps enhance the effectiveness of chemotherapy and increases survival rates.

  • Primary Cytoreductive Surgery
    This surgery is performed initially to achieve complete tumor resection in early-stage cancer or optimal debulking (less than 1 cm of residual tumor) in advanced cases.
  • Interval Cytoreduction
    This surgery occurs after three cycles of neoadjuvant chemotherapy, which aims to shrink the tumors, thus improving the chances of successful resection.
  • HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
    This method involves delivering heated chemotherapy directly into the abdominal cavity during surgery, following a cytoreduction for patients with stage III disease.
  • After Diagnostic Confirmation
    Surgery is necessary to confirm the diagnosis through biopsy. It also stages the disease via peritoneal washings, omentectomy, and lymphadenectomy—all essential for apparent early-stage cases.
  • For Advanced or Recurrent Disease
    If upfront optimal debulking isn’t feasible (in more than 50% of stage III/IV cases), neoadjuvant chemotherapy is used before interval surgery. Secondary cytoreduction may also address recurrences that are sensitive to platinum-based therapies.
  • For Fertility Preservation
    In young women with stage I disease who wish to retain their fertility, a unilateral salpingo-oophorectomy combined with staging is appropriate. This differs from the radical procedures often used in postmenopausal patients.

Ovarian cancer surgery is performed under general anesthesia, either through a laparotomy (preferred for debulking) or laparoscopy (typically used for early staging). The surgery lasts between 2 to 6 hours, depending on the complexity. Comprehensive staging includes examining over 20 peritoneal sites, removing the omentum and appendix, and sampling the lymph nodes. Patients are usually able to resume oral intake within 1 to 3 days after uncomplicated procedures. Recovery can take 4 to 8 weeks, during which the management of drains is important to prevent infection.

Benefits of Surgery for Ovarian Cancer

Achieving no visible residual disease can double the median survival rate from 23 to 50 months. Staging also helps guide adjuvant therapy, while fertility-sparing options can preserve reproductive potential.

WhatsApp Cancer Care
Get Your Free Cancer Diet Plan & Report Analysis Now on WhatsApp

Talk to experts. Understand your reports. Get a personalized diet plan — all free to start.

Get My Free Plan on WhatsApp
India's First Cancer Care Management Platform
Free to startSecure & privateNo app download needed

side -effects-and -risks

Potential complications include infection (10%), thromboembolism (5%), bowel injury (3-5%), and prolonged ileus. Surgery may also induce menopause, leading to vasomotor symptoms, which can be managed with hormone replacement therapy in select low-risk cases.

Caring for Yourself After Surgery for Ovarian Cancer

Monitor incision sites for redness or drainage, begin walking early to prevent blood clots, and follow a clear liquid diet until you can tolerate more solid foods. Maintain pelvic rest to avoid straining for six weeks. Consulting a nutritionist can help optimize wound healing and improve tolerance to chemotherapy. Follow-up scans will assess any residual disease before starting adjuvant therapy.

Why Choose Everhope

At Everhope Oncology, we have fellowship-trained gynecologic oncologists who specialize in minimally invasive techniques and HIPEC, achieving optimal debulking rates that surpass national averages. Our integrated approach combines precision surgery, molecular profiling, and intravenous nutritional support to enhance recovery and improve long-term outcomes.

FAQs

Yes, it is safe for early staging, but an open approach is preferred for cytoreduction.

It is recommended for upfront unresectable disease or for patients with poor performance status.

This is possible with unilateral procedures in stage IA.

Intravenous micronutrients help combat postoperative catabolism.